Welcome to our dedicated page for 3-D Sys Del news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3-D Sys Del stock.
3D Systems Corporation (NYSE: DDD), a pioneer in additive manufacturing and digital dentistry solutions, provides investors and industry professionals with critical updates through this centralized news hub. Track official press releases, financial disclosures, and strategic developments from the company redefining 3D printing applications across healthcare, aerospace, and industrial manufacturing.
This resource offers timely access to earnings announcements, regulatory filings, and innovation milestones. Users will find updates on advanced manufacturing technologies like the Oqton Manufacturing OS, healthcare breakthroughs in patient-specific medical devices, and industrial applications of QuickCast Air investment casting solutions.
Key content categories include quarterly financial results, product launches, strategic partnerships, and regulatory compliance achievements. The curated collection serves as a reliable reference for assessing 3D Systems' market position and technological leadership in high-precision manufacturing.
Bookmark this page to stay informed about DDD's progress in materials science advancements, software platform enhancements, and global manufacturing initiatives. Check regularly for verified updates directly impacting investment decisions and industry analysis.
3D Systems (NYSE:DDD) has confirmed the successful verification of mechanical properties for NASA's new laser powder bed fusion super alloy, GRX-810. This innovative alloy is designed for aerospace applications, showcasing exceptional strength, ductility, heat resistance, and creep life.
Using its Direct Metal Printing platform, 3D Systems processed and tested GRX-810, marking a significant milestone for materials in aerospace components. These properties present opportunities to replace traditional nickel-based super alloys in critical engine parts.
Dr. Michael Shepard from 3D Systems emphasized the potential of GRX-810 and the company’s commitment to advancing additive manufacturing in aerospace.
The University Hospital of Salzburg has successfully performed a groundbreaking surgery using a 3D-printed PEEK cranial implant for a patient suffering from skull deformity. This significant advancement utilized 3D Systems' Kumovis R1 printer and Oqton's D2P and Geomagic Freeform software to create a patient-specific implant. With the cranial implants market projected to exceed $2 billion by 2030, this innovation positions 3D Systems favorably within a rapidly growing sector. The PEEK material utilized is lightweight and mimics the mechanical properties of bone, enhancing patient comfort. The successful application of these technologies demonstrates the potential for improved orthopedic outcomes in personalized healthcare.
3D Systems (NYSE: DDD) announced it will release its first quarter 2023 financial results after the U.S. markets close on May 8, 2023. The company will host a conference call to discuss these results on May 9, 2023, at 8:30 a.m. Eastern Time. Investors can join the discussion via webcast or by telephone at 201-689-8345. A replay of the call will be available about two hours after its conclusion. 3D Systems continues to position itself as a leader in additive manufacturing, servicing markets such as healthcare, automotive, and aerospace with its innovative solutions.
Systemic Bio, a subsidiary of 3D Systems (NYSE:DDD), has announced the opening of a new 15,000 sq. ft. facility in Houston's TMC Innovation Factory Labs. This state-of-the-art location is dedicated to the R&D and production of the h-VIOS™ organ-on-a-chip platform, which allows for the testing of pharmaceutical drugs using human cells. The facility features cleanroom manufacturing to support sterile production and aims to fulfill multiple contracts with pharmaceutical companies over the next year. Jeremy Carter joins as Vice President of Operations to oversee this new venture, which marks a significant milestone in Systemic Bio’s drug discovery initiatives.
3D Systems (NYSE: DDD) has partnered with TE Connectivity to develop an innovative additive manufacturing solution for producing electrical connectors that meet stringent UL regulatory standards. The collaboration introduces a novel photopolymer that allows for production within weeks, significantly reducing lead times compared to traditional methods. This first-ever UL-recognized photopolymer has passed long-term thermal aging tests, displaying exceptional properties such as a flammability rating of UL94 V0 at 0.4mm thickness. With this new technology, TE Connectivity can efficiently produce complex geometries and adapt to low-volume production demands, enhancing its competitive edge in the market.
3D Systems announced major enhancements to its digital dentistry portfolio with the introduction of innovative materials, NextDent Base and NextDent Cast, designed for improved mechanical properties. The NextDent LCD1 printer, a compact and user-friendly device, is now available, enabling clinics to adopt 3D printing to enhance efficiency and patient experience. NextDent Base is a third-generation denture base material with high break resistance and aesthetic options, while NextDent Cast offers easy burn-out features for various dental applications. These products aim to streamline workflows and improve results in dental practices.
3D Systems (NYSE:DDD) has launched VSP Connect, a cloud-based surgical planning portal that integrates automated workflows and AI technologies to enhance collaboration and efficiency in patient-specific surgeries. Powered by Enhatch, VSP Connect aims to reduce planning times, improve communication between stakeholders, and streamline the preoperative process. The platform provides real-time patient case visualization, facilitating compliance and traceability in surgical planning. With over 150,000 patient-specific cases planned and more than 2 million implants manufactured, 3D Systems continues to lead in personalized healthcare solutions.
3D Systems Corporation (NYSE:DDD) reported a Q4 2022 revenue of $132,732, down 12.0% year-over-year, influenced by weakness in the dental orthodontics market. The full-year revenue was $538,031, reflecting a 12.6% decline from 2021. The company posted a net loss of $25,553 in Q4, totaling $122,711 for the year, leading to diluted losses of $0.20 and $0.96 per share respectively. Despite challenges, the company anticipates mid-single digit revenue growth in 2023, supported by strong performance in Industrial and Healthcare segments. The company projects Adjusted EBITDA to break even or better and maintains a robust cash position of $568,737.
3D Systems (NYSE: DDD) announced a restructuring initiative aimed at enhancing operational efficiencies. This initiative includes optimizing European metal printer operations and streamlining software organization, expected to cut operating expenses by $2.5 million to $3.5 million in 2023, and annual savings of $5.5 million to $7.0 million from 2024 onwards. The engineering and manufacturing consolidation of metal printers aims to improve product introduction cycles. Additionally, the merger of software development structures will yield cost savings through integration. Activities will commence immediately and conclude by mid-2023, reinforcing 3D Systems' commitment to operational excellence.
3D Systems (NYSE: DDD) announced that BWT Alpine F1 Team has purchased four SLA 750 3D printing systems to enhance productivity and part quality in its operations. This acquisition allows the team to produce 25,000 parts annually, significantly improving wind tunnel testing models using 3D Systems’ Accura Composite PIV material. The SLA 750 systems were chosen after rigorous testing, demonstrating superior print quality and efficiency. BWT Alpine F1 Team highlighted the systems' ability to reduce build times while maintaining high geometric accuracy and surface quality, ultimately accelerating innovation and design iteration.